A Booster Study of S-268019 in Japan (COVID-19)
Phase 2
- Conditions
- Prevention of COVID-19
- Registration Number
- JPRN-jRCT2031210470
- Lead Sponsor
- agata Tsutae
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot Recruiting
- Sex
- All
- Target Recruitment
- 204
Inclusion Criteria
Participant must be >= 20 years of age inclusive, at the time of signing the informed consent.
Participant who have received 2 doses of COMIRNATY and at least 6 months post second dose.
Exclusion Criteria
Positive SARS-CoV-2 antigen test result at Screening.
A known history of SARS-CoV-2 infection as determined by medical interview before study intervention.
Participant has a contraindication to IM injections or blood draws.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method SARS-CoV-2 neutralizing antibody titer on Day 29
- Secondary Outcome Measures
Name Time Method